Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Hematology Oncology Consultant, Hematology - Louisiana North Job
Celgene Corporation - Louisiana, LA, US
Associate Director, Global Production Planning & Inventory Control Job
Celgene Corporation - Basking Ridge, NJ, US
Principal Scientist
Watson Pharmaceuticals - Fort Lauderdale, FL
Manager, Strategic Forecasting & Analytics Job
Celgene Corporation - Basking Ridge, NJ, US
Patient Support Specialist Job
Celgene Corporation - Berkeley Heights, NJ, US

More Jobs >>

Events

New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA
Health Market Science Webinar: 3 Steps to New Physician Opportunities
Nov. 17
Life Science in the Cloud
Nov 16, 2011 — Cambridge, MA
Biomarker Applications for Improved Clinical Trial Outcomes
Nov. 15-16 — Boston

More Events >>

Related Tags >> flu vaccine adjuvant H1N1

SciClone News

Most Popular SciClone Story

SciClone stock surges on Zadaxin news

January 12, 2010 — 3:57pm ET | By Liz Jones Hollis

California-based SciClone Pharmaceuticals' shares shot up as much as 14 percent earlier this week after preliminary study data showed the adjuvant Zadaxin increased immune response when used in Read more...

SciClone Press Releases

SciClone Acquires NovaMed Pharmaceuticals Further Establishing It as a Leading China-Focused Specialty Pharmaceutical Company
SciClone Announces Topline Results From Phase 2b Clinical Trial of SCV-07 for Treatment of Chronic Hepatitis C
SciClone Pharmaceuticals, Inc. Secures $6 Million in Debt Financing From Silicon Valley Bank

Latest Headlines

SciClone stock surges on Zadaxin news
January 12, 2010

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK